Molecular Therapy - Oncolytics

4.6(top 5%)

impact factor

805(top 20%)

papers

12.9K(top 20%)

citations

42(top 20%)

h-index

4.7(top 10%)

extended IF

819

all documents

14.9K

doc citations

73(top 20%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Toxicity and management in CAR T-cell therapy	Molecular Therapy - Oncolytics	2016	686
2	Clinical manufacturing of CAR T cells: foundation of a promising therapy	Molecular Therapy - Oncolytics	2016	460
3	Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22	Molecular Therapy - Oncolytics	2018	191
4	Chimeric antigen receptor T-cell therapy for solid tumors	Molecular Therapy - Oncolytics	2016	191
5	Oncolytic Viruses for Cancer Therapy: Barriers and Recent Advances	Molecular Therapy - Oncolytics	2019	178
6	A Systematic Review of miR-29 in Cancer	Molecular Therapy - Oncolytics	2019	157
7	The Dual Role of Bone Morphogenetic Proteins in Cancer	Molecular Therapy - Oncolytics	2018	149
8	Curcumin inhibited HGF-induced EMT and angiogenesis through regulating c-Met dependent PI3K/Akt/mTOR signaling pathways in lung cancer	Molecular Therapy - Oncolytics	2016	134
9	CAR models: next-generation CAR modifications for enhanced T-cell function	Molecular Therapy - Oncolytics	2016	128
10	Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas	Molecular Therapy - Oncolytics	2018	123
11	B7-H3 as a Novel CAR-T Therapeutic Target for Glioblastoma	Molecular Therapy - Oncolytics	2019	120
12	CD19 CAR T Cells Expressing IL-12 Eradicate Lymphoma in Fully Lymphoreplete Mice through Induction of Host Immunity	Molecular Therapy - Oncolytics	2018	107
13	Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds	Molecular Therapy - Oncolytics	2019	107
14	Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin’s Lymphoma	Molecular Therapy - Oncolytics	2019	101
15	CXCR1 Expression to Improve Anti-Cancer Efficacy of Intravenously Injected CAR-NK Cells in Mice with Peritoneal Xenografts	Molecular Therapy - Oncolytics	2020	90
16	Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell Therapy	Molecular Therapy - Oncolytics	2017	88
17	Regulation of Glycolysis by Non-coding RNAs in Cancer: Switching on the Warburg Effect	Molecular Therapy - Oncolytics	2020	87
18	Designing herpes viruses as oncolytics	Molecular Therapy - Oncolytics	2015	76
19	Enhancement of PSMA-Directed CAR Adoptive Immunotherapy by PD-1/PD-L1 Blockade	Molecular Therapy - Oncolytics	2017	74
20	An MHC-restricted antibody-based chimeric antigen receptor requires TCR-like affinity to maintain antigen specificity	Molecular Therapy - Oncolytics	2016	71
21	Efficacy and Safety of CD28- or 4-1BB-Based CD19 CAR-T Cells in B Cell Acute Lymphoblastic Leukemia	Molecular Therapy - Oncolytics	2020	68
22	B7-H3-Targeted CAR-T Cells Exhibit Potent Antitumor Effects on Hematologic and Solid Tumors	Molecular Therapy - Oncolytics	2020	67
23	Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism	Molecular Therapy - Oncolytics	2021	66
24	Oncolytic Virus-Based Cytokine Expression to Improve Immune Activity in Brain and Solid Tumors	Molecular Therapy - Oncolytics	2019	64
25	Molecular profiles of small cell lung cancer subtypes: Therapeutic implications	Molecular Therapy - Oncolytics	2021	64
26	Oncolytic vesicular stomatitis virus expressing interferon-σ has enhanced therapeutic activity	Molecular Therapy - Oncolytics	2016	63
27	Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy	Molecular Therapy - Oncolytics	2016	63
28	Two-Dimensional Regulation of CAR-T Cell Therapy with Orthogonal Switches	Molecular Therapy - Oncolytics	2019	62
29	The Enhanced Tumor Specificity of TG6002, an Armed Oncolytic Vaccinia Virus Deleted in Two Genes Involved in Nucleotide Metabolism	Molecular Therapy - Oncolytics	2019	61
30	Analysis of Lung Adenocarcinoma Subtypes Based on Immune Signatures Identifies Clinical Implications for Cancer Therapy	Molecular Therapy - Oncolytics	2020	60
31	CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities	Molecular Therapy - Oncolytics	2022	60
32	Long non-coding RNAs: Biogenesis, functions, and clinical significance in gastric cancer	Molecular Therapy - Oncolytics	2021	59
33	Rapidly Switchable Universal CAR-T Cells for Treatment of CD123-Positive Leukemia	Molecular Therapy - Oncolytics	2020	57
34	Functional Gene Knockout of NRF2 Increases Chemosensitivity of Human Lung Cancer A549 Cells In Vitro and in a Xenograft Mouse Model	Molecular Therapy - Oncolytics	2018	56
35	High Expression of Pseudogene PTTG3P Indicates a Poor Prognosis in Human Breast Cancer	Molecular Therapy - Oncolytics	2019	56
36	M2 macrophage-derived exosomal microRNA-155-5p promotes the immune escape of colon cancer by downregulating ZC3H12B	Molecular Therapy - Oncolytics	2021	56
37	Chimeric antigen receptor–engineered T cells as oncolytic virus carriers	Molecular Therapy - Oncolytics	2015	53
38	Tumor-Secreted Exosomal lncRNA POU3F3 Promotes Cisplatin Resistance in ESCC by Inducing Fibroblast Differentiation into CAFs	Molecular Therapy - Oncolytics	2020	53
39	Characterization of the fatty acid metabolism in colorectal cancer to guide clinical therapy	Molecular Therapy - Oncolytics	2021	50
40	Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus	Molecular Therapy - Oncolytics	2018	49
41	Efficacy of a Third-Generation Oncolytic Herpes Virus G47Δ in Advanced Stage Models of Human Gastric Cancer	Molecular Therapy - Oncolytics	2020	48
42	Carboranes as unique pharmacophores in antitumor medicinal chemistry	Molecular Therapy - Oncolytics	2022	48
43	Abscopal Effect in Non-injected Tumors Achieved with Cytokine-Armed Oncolytic Adenovirus	Molecular Therapy - Oncolytics	2018	47
44	Natural Killer Cells: Diverse Functions in Tumor Immunity and Defects in Pre-neoplastic and Neoplastic Stages of Tumorigenesis	Molecular Therapy - Oncolytics	2020	45
45	Fascin actin-bundling protein 1 in human cancer: Promising biomarker or therapeutic target?	Molecular Therapy - Oncolytics	2021	45
46	ENO1 and Cancer	Molecular Therapy - Oncolytics	2022	45
47	Exosomal Leucine-Rich-Alpha2-Glycoprotein 1 Derived from Non-Small-Cell Lung Cancer Cells Promotes Angiogenesis via TGF-β Signal Pathway	Molecular Therapy - Oncolytics	2019	44
48	Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment	Molecular Therapy - Oncolytics	2019	44
49	Systematic profiling of ferroptosis gene signatures predicts prognostic factors in esophageal squamous cell carcinoma	Molecular Therapy - Oncolytics	2021	44
50	Single-cell RNA sequencing in cancer: Applications, advances, and emerging challenges	Molecular Therapy - Oncolytics	2021	44

Scientometrics

Overviews

Citing Bodies

Molecular Therapy - Oncolytics

Top Articles